Nestle has launched in China its first growing up formula containing human milk oligosaccharides (HMOs), namely 2'-fucosyllactose (2'FL) and lacto-N-(neo)tetraose (LNnT).
Human milk oligosaccharides (HMOs) are now officially permitted for use in China’s infant formula, with two multinationals, namely IFF and dsm-firmenich, as well as local dairy giant Mengniu, announcing that they have received approvals in the past week.
The US FDA has issued ‘Good Day Letters’ to dsm-firmenich for three Generally Recognized as Safe (GRAS) notices submitted for the human milk oligosaccharides (HMOs) LNFP-l/2’-FL and hypoallergenic grade LNnT and 2’-FL.
Junlebao Dairy Group has launched its Nutrition Science Strategy, aiming to strengthen the science behind its products, as well as to identify novel functional ingredients.
Kirin’s first human milk oligosaccharides (HMOs) production plant has commenced operation and the company anticipates that half of the market will be dominated by China in the future.
Breastfeeding mothers with a higher intake of vegetables, vitamins and metal elements produced more human milk oligosaccharides (HMOs) in their breast milk, according to an observational study funded by Abbott Nutrition R&D Center in Shanghai.
Bacteria species that can feed on a wide range of human milk oligosaccharides (HMOs) are known to grow and dominate an infant’s gut microbiota, but this is not always the case, with a new research showing how the order of bacteria exposure could be more...
Prolacta Bioscience has announced the journal Cell Host & Microbe has published a proof-of-concept study evaluating the unique relationship between human milk oligosaccharides (HMOs) and the infant gut microbe Bifidobacterium longum subspecies infantis...
Human milk oligosaccharides (HMOs) — important groups of carbohydrates in human breast milk — can, in some cases, be secreted in very high concentrations, and still be safe and well-tolerated by infants.
On this week’s podcast, we have three conversations: with Ian Smith, sales director at PFF; Dr Ardythe Morrow, Professor of Epidemiology and Pediatrics at the University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical...
Adventa Bioscience, a company dedicated to improving adult human health, has announced the launch of Trulacta, the world's first and only supplement made entirely of human milk.
Belgian biotech company Inbiose, which develops human milk oligosaccharides (HMOs), has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) of four HMOs.
Abbott has launched Similac Pro-Advance with a 2'-Fucosyllactose Oligosaccharide (2'-FL) not derived from breast milk, making it the first product in Canada with the ingredient in infant formula.
